• Explore /
  • Poster
  • / Identification of biomarkers for TAS-102 efficacy in metastatic colorectal cancer patients based on preclinical analysis and clinical validation.

Identification of biomarkers for TAS-102 efficacy in metastatic colorectal cancer patients based on preclinical analysis and clinical validation.

Abstract Poster

Authors

null

Mitsukuni Suenaga

Japanese Foundation for Cancer Research, Tokyo, Japan

Mitsukuni Suenaga , Tetsuo Mashima , Naomi Kawata , Shingo Dan , Takeru Wakatsuki , Eiji Shinozaki , Takashi Ichimura , Mariko Ogura , Daisuke Takahari , Hiroki Osumi , Yumiko Ota , Keisho Chin , Hiroyuki Seimiya , Kensei Yamaguchi , Toshiharu Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 669)

DOI

10.1200/JCO.2018.36.4_suppl.669

Abstract #

669

Poster Bd #

F6

Abstract Disclosures

Similar Posters

First Author: Mitsukuni Suenaga

First Author: Anwaar Saeed

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Real-world treatment patterns and unmet need in patients with previously treated metastatic colorectal cancer that is not MSI-H or dMMR.

Real-world treatment patterns and unmet need in patients with previously treated metastatic colorectal cancer that is not MSI-H or dMMR.

First Author: Kaushal Desai

First Author: Arvind Katta